ExodusPoint Capital Management »

Stoke Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.2M 130k 32.72
2022-09-30 $202k 16k 12.86
2020-12-31 $306k 4.9k 61.89

More positions owned by ExodusPoint Capital Management

Amazon Put Option (AMZN)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple Put Option (AAPL)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
NVIDIA Corporation Put Option (NVDA)
Topbuild
Penumbra (PEN)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Shopify Cl A Sub Vtg Shs Call Option (SHOP)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Intel Corporation Put Option (INTC)
Select Sector Spdr Tr St Str Finl Etf (XLF)
Microsoft Corporation (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Stoke Therapeutics

BlackRock
Rtw Investments
FMR
Lynx1 Capital Management
Redmile Group
Wellington Management Company
Morgan Stanley
Baker Bros. Advisors
Toronto-Dominion Bank
Vanguard Capital Management
BVF
State Street Corporation
Siren
T. Rowe Price Associates
Deerfield Management Company

View all funds holding Stoke Therapeutics